Cadence, a startup in the digital health sector, has announced a significant funding round, securing $100 million to bolster its efforts in chronic disease management.
This funding elevates Cadence's valuation to $1.23 billion, reflecting growing investor interest in healthcare solutions that leverage artificial intelligence.
The company aims to use this capital to expand its program focused on automating care for chronic diseases, a critical area in healthcare.